Skip to main content

Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Abstract

We report three cases of severe hypocalcaemia associated with i.v. bisphosphonate treatment in patients with multiple myeloma. All patients had symptomatic hypocalcaemia, including a tonic-clonic seizure and tachyarrhythmia in one case. Two cases were associated with the development of acute renal failure, whereas the third patient had pre-existing renal impairment. We recommend that bisphosphonates be used with caution in patients with myeloma and renal impairment, that vitamin D deficiency be corrected prior to treatment (to reduce the risk of hypocalcaemia) and that serum calcium and renal function be monitored during treatment. (Intern Med J 2005; 35: 726–728)

Keywords: bisphosphonate; hypocalcaemia; multiple myeloma; pamidronate; zoledronate

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1445-5994.2005.00949.x

Affiliations: 1: Department of Endocrinology and Diabetes, Royal Perth Hospital 2: Endocrinology and Diabetes 3: Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

Publication date: December 1, 2005

bsc/imj/2005/00000035/00000012/art00009
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more